Why Language Matters: Using Respectful Terms in Breast Cancer Care

Professor Fran Boyle is a highly experienced Medical Oncologist who specialises in the areas of breast cancer and melanoma. She is passionate about making advances in this field, and her practice focuses on researching new treatments as well as developing care and communication.

We spoke with Professor Boyle about the importance of using respectful and inclusive language in breast cancer care, so that patients can understand and make informed decisions about their treatment.

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Guest: Professor Fran Boyle

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠

Science and Hope: How Research is Changing Breast Cancer Treatment

Elissa Simms is a mum of two daughters, 20-year-old Bryn and 17-year-old Ella, who enjoys spending time with her family and walking her dogs Kahlua and Lottie.

In March 2024, Elissa noticed a strange sensation in her breast. At the time, she was seeing her GP frequently as she was dealing with a frozen shoulder and thought the two might be connected. Unfortunately, after being sent for an ultrasound, she was diagnosed with breast cancer.

We spoke with Elissa about her diagnosis, navigating breast cancer, and her participation in the OPTIMA clinical trial.

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Guest: Elissa Simms

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠

Receiving a Shock Diagnosis: The Importance of Supporting Clinical Trials Research

Tamara Dawes is a mum and primary school teacher living in NSW, who enjoys living in the country, going to the beach, and spending time with her family and their dog.

Around Easter time in 2021, Tamara had been dealing with some eczema. Because of this, she had been performing frequent self-examinations, and noticed a lump in her breast. She booked in with her GP, who sent her for a mammogram, biopsy and ultrasound and two days later was diagnosed with breast cancer.

We spoke with Tamara about her shock diagnosis, navigating breast cancer with a young family and the importance of supporting breast cancer clinical trials research.

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Guest: Tamara Dawes

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠

Navigating Breast Cancer: A Patient's Perspective of the CAMBRIA-2 Clinical Trial

Wendy Rolls is a wife and mum of three daughters from New South Whales, Australia who enjoys golf, quilting, scrapbooking, and spending time with her family. In October 2023, Wendy found a small lump in her breast, and after undergoing a number of tests including an ultrasound, needle biopsy, and core biopsy she was diagnosed with breast cancer.

We spoke with Wendy about her diagnosis, navigating breast cancer, and her participation on the CAMBRIA-2 clinical trial.

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Guest: Wendy Rolls, CAMBRIA-2 Clinical Trial Participant

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠

Bridging Science and Personal Experience: The Role of the Consumer Advisory Panel

The Breast Cancer Trials Board of Directors established the Consumer Advisory Panel, also known as CAP, in 1998 because it recognised the value and importance of consumer input to the planning and conduct of clinical trials research. CAP members bring their own unique experience of breast cancer and a true commitment to the clinical trials research process.

In this episode, you'll hear from our former CAP Chair, Leslie Gilham, as well as three of our members, Merryn Carter, Naveena Nekkalapudi, and Laura McCambridge, as they discuss the Consumer Advisory Panel of Breast Cancer Trials, their role, and what you can expect from being involved.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠⁠

Guests: The Breast Cancer Trials Consumer Advisory Panel

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠

Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer

Dr Erica Mayer is the director of clinical research and institute physician at the Breast Oncology Centre, Dana-Faber Cancer Institute, and associate professor of medicine at Harvard Medical School in Boston, United States.

Dr Mayer's research focuses on the role of novel therapies in the treatment of breast cancer and we spoke with her about improving efficacy in the adjuvant treatment of early ER+ breast cancer.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠

Guest: Dr Erica Mayer

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠⁠Breast Cancer Trials⁠⁠⁠

Cracking the Code: Biomarkers and the Fight Against Hormone Therapy Resistance

Professor Andrew Tutt is a Consultant Clinical Oncologist in the Breast Cancer Unit at Guy's and St Thomas' NHS Foundation Trust. He is also a Professor of Oncology at King's College in London. We spoke to him about biomarkers for hormone therapy resistance and deficiency, and on targeting the Achilles heel in BRCA1 and BRCA2 gene mutations.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠

Guest: Professor Andrew Tutt

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠⁠Breast Cancer Trials⁠⁠

Is Less More? Rethinking the Future of Breast Cancer Surgery

Professor Michael Gnant is a Professor of Surgery at the Medical University of Vienna, Austria, where he also serves as President of the Austrian Breast and Colorectal Cancer Study Group. We spoke to him about trends in surgery de-escalation and management of the axilla.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠

Guest: Professor Michael Gnant

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: ⁠Breast Cancer Trials⁠

How to Select the Right Patients for Volume Replacement Therapy

Peter Barry is a Consultant Surgeon at the Breast Unit, Royal Marsden in London. He focuses on breast oncoplastic techniques and reconstructive options following cancer surgery, as well as preventative surgery for high-risk women. We spoke with him about selecting patients for volume replacement therapy.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠

Guest: Mr Peter Barry

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.

Find out more: Breast Cancer Trials

DCIS & The Risk of Local Recurrence: What You Need to Know

Dr Christina Kozul is a Royal Australasian College of Surgeons Accredited General Surgical trainee at The Royal Melbourne Hospital, who aims to subspecialise in Breast Surgery.

She is passionate about contributing to breast cancer research to improve outcomes for women with DCIS and breast cancer. We spoke with Dr Kozul about Ductal Carcinoma in Situ, and why the risk of local recurrence might be a concern for some women.

Tune in for a deep dive into this important research.

⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media: 

• Instagram:⁠ ⁠⁠⁠@breastcancertrials⁠⁠⁠⁠ 
• Facebook:⁠ ⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠ 
• LinkedIn: ⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠ 
• X: ⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠

Guest: Dr Christina Kozul

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research.